About ElixirTrials

Building the future of clinical research

We're on a mission to ensure that clinical trials reflect real-world diversity by building clinical trial capabilities at healthcare sites in underserved communities.

Our Mission

Clinical trials are failing diversity. Fewer than 5% of U.S. patients participate in trials, and most participants don't reflect the real-world population. This creates a critical gap in healthcare equity and delays life-saving treatments.

Elixir Trials is building the infrastructure to bring clinical research to every community. We partner with community hospitals to create turnkey trial capabilities, ensuring that cutting-edge treatments reach the patients who need them most.

Expanding Access
Elevating Equity
Powering Trials
88%
U.S. health centers lack trial infrastructure
<5%
U.S. patients participate in trials
$69.8B
Global trials market by 2027
80%
Trials miss enrollment targets

Our Values

The principles that guide everything we do

Health Equity First

We believe every patient deserves access to cutting-edge treatments, regardless of their zip code or background.

Quality & Safety

Maintaining the highest standards of clinical research while expanding access to underserved communities.

Innovation Through Partnership

Building bridges between academic medical centers and community hospitals to advance medical science.

Community-Centered

Working with local healthcare providers to build sustainable research capabilities that serve their communities.

Our Team

Healthcare innovators, technology leaders, and community advocates working together

Heather background
Heather headshot

Heather

CEO & Co-Founder

Heather Grey is a healthcare executive with 15+ years of experience leading clinical trial and real-world data businesses. She has built and scaled trial infrastructure and data commercialization strategies, closing multimillion-dollar pharma partnerships and launching innovative trial recruitment models. Heather has a proven track record of accelerating sponsor collaborations, expanding access to diverse patient populations, and delivering high-impact RWD solutions.

Clinical Trial Operations, Site Development
LinkedIn
Noah background
Noah headshot

Noah

CTO & Co-Founder

Lt. (res) Noah Dolev, ex-astronaut candidate, holds a Phd (magna cum laude) in computational neuroscience. For over 15 years, he has been leading and contributing to novel AI solutions from digital pathology to transcriptomics. With a deep statistical and scientific understanding, Noah has contributed to AI products as a CSO, Head of R&D, lead statistician, clinical data scientist and algorithm developer. He has been a part of 6 startups, including two unicorns and knows well how to turn AI concepts into products.

AI Solutions, Product Development
LinkedIn

Our Journey

Building the future of clinical research, one milestone at a time

Coming Soon

Our journey timeline is being updated with the latest milestones and achievements.

2024

Company Founded

ElixirTrials launched with a mission to democratize clinical trial access

2024

Pilot Program Launch

Partnered with 3 community hospitals to test our infrastructure model

2025

Series A Funding

Raised $15M to scale our platform and expand to 20+ sites

2025

FDA Partnership

Collaborating with FDA to develop diversity-focused trial guidelines

Ready to transform clinical research?

Join us in building a more equitable future for clinical trials. Whether you're a hospital, sponsor, or patient advocate, we'd love to hear from you.

Learn More